Ezra (EZRA) Stock Price, News & Analysis

Company Overview

Ezra (NASDAQ: EZRA) is a health care technology company focused on improving cancer screening and early detection. The company combines magnetic resonance imaging (MRI) with artificial intelligence to help identify potential cancer and other abnormalities, with the goal of making screening more accessible, efficient and comprehensive.

Its services include Ezra Screen, an MRI-based screening program designed to examine multiple areas of the body in a single session, as well as related imaging and cancer-screening services. Ezra’s artificial intelligence tools are intended to assist radiologists in reviewing scans and identifying findings that may require further evaluation; they are not a substitute for a physician’s diagnosis.

Ezra was founded in 2018 by Emi Gal, who has served as the company’s chief executive officer. The company’s screening services are offered through a network of imaging centers in the United States. Availability and the specific services provided may vary by location and applicable medical and regulatory requirements.

Key Stats

• Today's Range: $1.95 to $2.02
• 50-Day Range: $1.95 to $3.03
• 52-Week Range: $1.75 to $53.20
• Volume: 11,948 shs
• Average Volume: 781,026 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Ezra Stock Analysis - MarketRank™

Ezra scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Ezra has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Ezra has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: N/A
• Proj. Earnings Growth: N/A

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Ezra has a short interest ratio ("days to cover") of 0.28, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Ezra has recently decreased by 52.38%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ezra does not currently pay a dividend.

Dividend Growth

Ezra does not have a long track record of dividend growth.

News and Social Media

• Score: 1.9 / 5
• News Sentiment: 0.04

News Sentiment

Ezra has a news sentiment score of 0.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 10 news articles for Ezra this week, compared to 4 articles on an average week.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Ezra insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $124,161.00 in company stock.

Percentage Held by Institutions

Ezra has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 7/30/2026
• Today: 10/12/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Finance
• Industry: Insurance
• Sub-Industry: Insurance Brokers
• Current Symbol: NASDAQ:EZRA
• CIK: 1812727
• Web: www.relianceglobalgroup.com
• Phone: (732) 780-4647
• Fax: N/A
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $11.05 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A